SAR-446959

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameSAR-446959

Drug Alias NameSAR446959SAR-446959

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)

Mechanisms of ActionADAMTS5 inhibitorsMatrix metalloproteinase 13 inhibitors

TargetsADAMTS5Matrix metalloproteinase 13

Therapy Area/IndicationsOsteoarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Develop Information

Active CompaniesSanofi

Inactive CompaniesN/A

Active IndicationsOsteoarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A